Rescuing the Function of Missense-Mutated Tumor Suppressor VHL using Stabilizing Small Molecules.

Saved in:
Bibliographic Details
Title: Rescuing the Function of Missense-Mutated Tumor Suppressor VHL using Stabilizing Small Molecules.
Authors: Fouad MA; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia PA., Parry CS; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia PA.; MD/PhD Program, Lewis Katz School of Medicine at Temple University, Philadelphia, PA., Miller SA; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia PA., Malhotra S; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia PA., Doyle GA; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia PA., Shimabenga E; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia PA., Nurilloeva M; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia PA., Bondarenko E; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia PA.; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia PA., Andrianov GV; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia PA., Childers W; Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, PA., Blass BE; Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, PA., Makhov PB; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia PA., Whetstine JR; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia PA.; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia PA., Clapper ML; Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia PA., Golemis EA; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia PA.; Department of Cancer and Cellular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA., Karanicolas J; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia PA.; Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, PA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 May 29. Date of Electronic Publication: 2026 May 29.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.64898/2026.01.02.697373